Your browser doesn't support javascript.
loading
Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages.
Raudszus, Rick; Paulig, Andrea; Urban, Nicole; Deckers, Anke; Gräßle, Simone; Vanderheiden, Sylvia; Jung, Nicole; Bräse, Stefan; Schaefer, Michael; Hill, Kerstin.
Afiliação
  • Raudszus R; Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.
  • Paulig A; Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.
  • Urban N; Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.
  • Deckers A; Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Gräßle S; Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Vanderheiden S; Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Jung N; Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Bräse S; Institute of Biological and Chemical Systems, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Schaefer M; Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany.
  • Hill K; Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.
Br J Pharmacol ; 180(21): 2736-2749, 2023 11.
Article em En | MEDLINE | ID: mdl-37254803
ABSTRACT
BACKGROUND AND

PURPOSE:

In macrophages, transient receptor potential vanilloid 2 (TRPV2) channel contributes to various cellular processes such as cytokine production, differentiation, phagocytosis and migration. Due to a lack of selective pharmacological tools, its function in immunological processes is not well understood and the identification of novel and selective TRPV2 modulators is highly desirable. EXPERIMENTAL

APPROACH:

Novel and selective TRPV2 modulators were identified by screening a compound library using Ca2+ influx assays with human embryonic kidney 293 (HEK293) cells heterologously expressing rat TRPV2. Hits were further characterized and validated with Ca2+ influx and electrophysiological assays. Phagocytosis and migration of macrophages were analysed and the contribution of TRPV2 to the generation of Ca2+ microdomains was studied by total internal reflection fluorescence microscopy (TIRFM). KEY

RESULTS:

The compound IV2-1, a dithiolane derivative (1,3-dithiolan-2-ylidene)-4-methyl-5-phenylpentan-2-one), is a potent inhibitor of heterologously expressed TRPV2 channels (IC50 = 6.3 ± 0.7 µM) but does not modify TRPV1, TRPV3 or TRPV4 channels. IV2-1 also inhibits TRPV2-mediated Ca2+ influx in macrophages. IV2-1 inhibits macrophage phagocytosis along with valdecoxib and after siRNA-mediated knockdown. Moreover, TRPV2 inhibition inhibits lipopolysaccharide-induced migration of macrophages whereas TRPV2 activation promotes migration. After activation, TRPV2 shapes Ca2+ microdomains predominantly at the margin of macrophages, which are important cellular regions to promote phagocytosis and migration. CONCLUSIONS AND IMPLICATIONS IV2-1 is a novel TRPV2-selective blocker and underline the role of TRPV2 in macrophage-mediated phagocytosis and migration. Furthermore, we provide evidence that TRPV2 activation generates Ca2+ microdomains, which may be involved in phagocytosis and migration of macrophages.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Macrófagos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Macrófagos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article